(Food-Beverage-News.Com, October 11, 2018 ) Galacto oligosaccharide (GOS) is gaining significant uptake in the infant nutrition industry on account of positive perception about its therapeutic effect on gut health and immunity development. Increase in the number of lactose intolerant population continues to be a challenge for policy makers. According to a journal published by the National Center for Biotechnology Information (NCBI) in 2017, around 70% of the world’s population suffer from lactose intolerance due to a genetically programmed gradual decline in lactase expression, known as lactase non-persistence (LNP). The availability of plant-based galacto oligosaccharide has proven to be highly beneficial with regards to meeting the nutritional requirements of the lactose intolerant population. The infant nutrition industry will be looking to capitalize on the opportunity presented by commercialization of plant-based galacto oligosaccharides.
FDA Approval Likely to Provide the Much-needed Fillip to Galacto Oligosaccharide Demand
The broader trends impacting the dietary fibers industry have a profound impact on the prospects of galacto oligosaccharide industry. The recent FDA approval on eight dietary fibers, including galacto oligosaccharide is likely to create a scramble for launching new products.. With this approval, key manufacturers are broadening the horizon of galacto oligosaccharide that could help them seize premium opportunities. Key dairy cooperative companies are using galacto oligosaccharide in beverages owing to its stability, as addition of fibers in beverages still remains a challenge due to their insolubility or grittiness.
Use of Galacto Oligosaccharide in the Nutraceuticals Industry Gaining Strong Momentum
The demand for galacto oligosaccharide in nutraceuticals is likely to grow at a steady clip during the assessment period. The stability of galacto oligosaccharide in high temperatures and low pH applications makes it an ideal fit for neutraceutical products. Prominent nutritional supplement products such as Bimuno, which is meant for the well-being of gut health, contains galacto oligosaccharide in its ingredient profile., The composition for galacto oligosaccharide in neutraceutical products might vary according to the chain length and linkage type between the monomer units.
Broader Regulations Pertaining to Use of Prebiotic Ingredients Can Stymie Prospects of Galacto Oligosaccharide Companies
Strict regulations and legislations related to the use of prebiotic ingredient can be a key factor hampering use of galacto oligosaccharide. Any product before receiving the recognition as a prebiotic or probiotic, is consistently subjected to multiple validations and has to persistently prove its efficacy. It cannot be directly labeled as such, until and unless it is approved by the concerned agencies. Being operating in the food ingredient industry, galacto oligosaccharide is exposed to similar kind of legislations by various food regulation authorities such as FDA and food and agriculture organization. This might create hurdles for prosperity of galacto oligosaccharide, thereby impacting the galacto oligosaccharide market landscape.
Liquid Galacto Oligosaccharide Continues to Outsell Powdered Variants; Latter Growing at Higher Rate
Galacto oligosaccharide products are available in both liquid and powder form. The liquid galacto oligosaccharide is foreseen to sustain its supremacy and is anticipated to hold around 59% of the global market share by 2028. The liquid galacto oligosaccharide finds extensive applications across food products such as beverages, fermented milk, & so on. The powder galacto oligosaccharide is expected to grow on a relentless rate with its use as an additive in infant formula and nutraceuticals
The competitive dynamics included in the report on galacto oligosaccharide market offers a deep dive into the competitive intensity of the market. The galacto oligosaccharide market is characterized by the presence of a limited number of players holding substantial shares. Some of the key players operating in the galacto oligosaccharide market, who have been profiled in the report include Yakult Pharmaceuticals Pvt Ltd, Royal Friesland Campina N.V, Nissin Sugar Co., Ltd., Ingredion Incorporated, Kerry Inc., Quantum Hi-Tech (China) Biological Co., Ltd., Dairy Crest., Baolingbao Biology Co., Ltd., Samyang Corporation, New Francisco Biotech Company.
A comprehensive taxonomy of galacto oligosaccharide market has been included in the report to address the quantitative aspects of each segment of the galacto oligosaccharide market. The product types available in the galacto oligosaccharide market are liquid galacto oligosaccharide and powder galacto oligosaccharide. The primary function type of products in galacto oligosaccharide market include prebiotic and sweetener. The end use types included in the report on galacto oligosaccharide market are food and beverage, animal feeds, and pharmaceutical & personal care. The galacto oligosaccharide market has been closely analyzed across regions of North America, Latin America, Europe, Asia Pacific, Japan, and Middle East & Africa.
Additional Questions Answered
Some of the additional questions answered in the report of galacto oligosaccharide market include-
Is use of galacto oligosaccharide in cosmetics creating a major impact on market?
How has use of galacto oligosaccharide for geriatric patients influenced the galacto oligosaccharide market?
How has significant health benefits obtained by adding galacto oligosaccharide in pet nutrition pumped growth of galacto oligosaccharide market?
How has extraction of plant based GOS from legumes encouraged proliferation of galacto oligosaccharide market?
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.